OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Expanding the horizons of targeted protein degradation: A non-small molecule perspective
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 16
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 16
Showing 16 citing articles:
Targeting the STAT3 pathway with STAT3 degraders
Zhijie Wang, Xiaotong Liao, Haiqi He, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 811-823
Closed Access | Times Cited: 5
Zhijie Wang, Xiaotong Liao, Haiqi He, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 811-823
Closed Access | Times Cited: 5
Optineurin restrains CCR7 degradation to guide type II collagen-stimulated dendritic cell migration in rheumatoid arthritis
Wenxiang Hong, Hongbo Ma, Zhaoxu Yang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Wenxiang Hong, Hongbo Ma, Zhaoxu Yang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
DNA Tetrahedron-Driven Multivalent Proteolysis-Targeting Chimeras: Enhancing Protein Degradation Efficiency and Tumor Targeting
Shiqing Li, Tao Zeng, Zhixing Wu, et al.
Journal of the American Chemical Society (2025)
Closed Access
Shiqing Li, Tao Zeng, Zhixing Wu, et al.
Journal of the American Chemical Society (2025)
Closed Access
Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
Lisha Ou, Mekedlawit Setegne, Jeandele Elliot, et al.
Chemical Reviews (2025)
Closed Access
Lisha Ou, Mekedlawit Setegne, Jeandele Elliot, et al.
Chemical Reviews (2025)
Closed Access
Application of Mass Spectrometry for the Advancement of PROTACs
Hao Yin, Baoshuang Zhang, Ruibing Chen
Journal of Pharmaceutical and Biomedical Analysis (2025), pp. 116829-116829
Closed Access
Hao Yin, Baoshuang Zhang, Ruibing Chen
Journal of Pharmaceutical and Biomedical Analysis (2025), pp. 116829-116829
Closed Access
Interplay of PROTAC Complex Dynamics for Undruggable Targets: Insights into Ternary Complex Behavior and Linker Design
Harish Kumar, M. Elizabeth Sobhia
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1306-1318
Closed Access | Times Cited: 3
Harish Kumar, M. Elizabeth Sobhia
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1306-1318
Closed Access | Times Cited: 3
Development of miRNA-based PROTACs targeting Lin28 for breast cancer therapy
Jianfei Xu, Xiaoran Zhao, Xingxing Liang, et al.
Science Advances (2024) Vol. 10, Iss. 38
Open Access | Times Cited: 3
Jianfei Xu, Xiaoran Zhao, Xingxing Liang, et al.
Science Advances (2024) Vol. 10, Iss. 38
Open Access | Times Cited: 3
Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates
Yuying Shi, Gang Fan, Ruirong Tan, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 9
Open Access | Times Cited: 3
Yuying Shi, Gang Fan, Ruirong Tan, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 9
Open Access | Times Cited: 3
Comprehensive approaches to preclinical evaluation of monoclonal antibodies and their next-generation derivatives
Santanu Singh, Kajal Kachhawaha, Sumit K. Singh
Biochemical Pharmacology (2024) Vol. 225, pp. 116303-116303
Closed Access | Times Cited: 1
Santanu Singh, Kajal Kachhawaha, Sumit K. Singh
Biochemical Pharmacology (2024) Vol. 225, pp. 116303-116303
Closed Access | Times Cited: 1
Discovery of novel KSP-targeting PROTACs with potent antitumor effects in Vitro and in Vivo
Deng‐Gao Zhao, J. Y. Liu, Zhiguang Su, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117052-117052
Closed Access | Times Cited: 1
Deng‐Gao Zhao, J. Y. Liu, Zhiguang Su, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117052-117052
Closed Access | Times Cited: 1
Treating ICB-Resistant Cancer by Inhibiting PD-L1 via DHHC3 Degradation Induced by Cell Penetrating Peptide-Induced Chimera Conjugates
Miao Liu, Yuying Shi, Ruirong Tan, et al.
Research Square (Research Square) (2024)
Closed Access
Miao Liu, Yuying Shi, Ruirong Tan, et al.
Research Square (Research Square) (2024)
Closed Access
Protacs in cancer therapy: mechanisms, design, clinical trials, and future directions
Akash Vikal, Rashmi Maurya, Brij Bihari Patel, et al.
Drug Delivery and Translational Research (2024)
Closed Access
Akash Vikal, Rashmi Maurya, Brij Bihari Patel, et al.
Drug Delivery and Translational Research (2024)
Closed Access
Nanotechnology‐Enabled Targeted Protein Degradation for Cancer Therapeutics
Wutong Zhao, Yongbin Jiang, Xiufen Li, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Closed Access
Wutong Zhao, Yongbin Jiang, Xiufen Li, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Closed Access
A novel ROR1-targeting antibody-PROTAC conjugate promotes BRD4 degradation for solid tumor treatment
Lei Wang, Yong Ke, Qunye He, et al.
Theranostics (2024) Vol. 15, Iss. 4, pp. 1238-1254
Open Access
Lei Wang, Yong Ke, Qunye He, et al.
Theranostics (2024) Vol. 15, Iss. 4, pp. 1238-1254
Open Access
Design and synthesis of nucleic acid nano-environment interactome-targeting small molecule PROTACs and their anticancer activity
Sadiya Tanga, Arkadeep Karmakar, Arpita Hota, et al.
Nanoscale (2024) Vol. 16, Iss. 26, pp. 12502-12509
Closed Access
Sadiya Tanga, Arkadeep Karmakar, Arpita Hota, et al.
Nanoscale (2024) Vol. 16, Iss. 26, pp. 12502-12509
Closed Access
Recent advances in organelle-specific autophagy in melanoma
Jinxin Qi, Qian Zhang, Lian Wang, et al.
ONCOLOGIE (2024)
Closed Access
Jinxin Qi, Qian Zhang, Lian Wang, et al.
ONCOLOGIE (2024)
Closed Access
